Delpharm
FranceEntry
2021
Hold
5yr
Status
Active
Who owns Delpharm?
Delpharm is a French Pharma company, currently owned by Idia since 2024 and Socadif.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Ownership history
2 ownership periods · co-invest detected · 2 lenders on file
Co-invest · 2 holders · 2 lenders · 2007 · present
Andera PartnersLender · repaid
2007 · Acto Mezzanine I · 2007 · Mezzanine
CIC Private DebtLender
2021 · present(5yr) · CM-CIC Debt Fund 3 · 2019 · Private Debt
SocadifActive
2021 · present(5yr) · SOCADIF · 1991 · Growth
IdiaActive
2024 · present(2yr) · IDIA Small & Midcap · 1990 · Buyout
More from SOCADIF
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Delpharm?
Delpharm is currently owned by Idia and Socadif, through SOCADIF, since 2024.
When did Idia and 1 other acquire Delpharm?
Idia and 1 other acquired Delpharm in 2024.
Who did Delpharm sell to?
Andera Partners sold Delpharm to Abénex Capital (Trade Sale).
Who has owned Delpharm over time?
Delpharm has been through 4 private-equity ownership periods: Andera Partners · via Acto Mezzanine I · since 2007 · sold to Abénex Capital · (Trade Sale); Socadif · via SOCADIF · since 2021; CIC Private Debt · via CM-CIC Debt Fund 3 · since 2021; Idia · via IDIA Small & Midcap · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue